📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The use of chemogenetic approaches to study the physiological roles of muscarinic acetylcholine receptors in the central nervous system. (2018)

First Author: Bradley SJ

Attributed to: Using a Designer Receptor Exclusively Activated by Designer Drug to define the role of short chain fatty acids in metabolic disease and inflammation funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.neuropharm.2017.11.043

PubMed Identifier: 29191752

Publication URI: http://europepmc.org/abstract/MED/29191752

Type: Journal Article/Review

Volume: 136

Parent Publication: Neuropharmacology

Issue: Pt C

ISSN: 0028-3908